Endocrine Abstracts

Contents

• Plenary Lectures
• • Clinical Endocrinology Journal Foundation Visiting Professor Lecture
  • • Abstract unavailable

      ea0117pl1
  • Society for Endocrinology Starling Early Career Medal for Research Excellence
  • • Using kisspeptin to interrogate hypothalamic dysfunction in reproductive disorders

      ea0117pl2
  • Society for Endocrinology Presidential Lecture
  • • Abstract unavailable

      ea0117pl3
  • Society for Endocrinology Dale Lifetime Achievement Medal
  • • Abstract unavailable

      ea0117pl4
  • British Thyroid Association Pitt-Rivers Lecture
  • • From mutation to medicine: a story of MCT8 deficiency

      ea0117pl5
  • Society for Endocrinology Outstanding Contribution Medal
  • • Stress, steroids and serendipity

      ea0117pl6
  • Society for Endocrinology Medal for Research Excellence (Clinical)
  • • Pituitary Troubles and the Mitos for the Labyrinth

      ea0117pl7
  • Society for Endocrinology Medal for Research Excellence (Science)
  • • Abstract unavailable

      ea0117pl8
  • Clinical Endocrinology Journal Foundation Lecture
  • • Abstract unavailable

      ea0117pl9
• Pitch Session
• • Should Weight-Loss Medications Be Routinely Offered for Managing Obesity in the NHS?
  • • Abstract unavailable

      ea0117d1.1
    • Abstract unavailable

      ea0117d1.2
    • Abstract unavailable

      ea0117d1.3
• Awards and Prizes
• • Outstanding Teacher of the Year Award
  • • My journey in medicine and endocrinology

      ea0117ta1
  • Outstanding Clinical Practitioner Awards
  • • First do no harm

      ea0117ocp1
    • Improving the treatment of patients with reproductive hormonal disorders

      ea0117ocp2
  • Nikki Kieffer Medal
  • • Abstract unavailable

      ea0117nkm1
• Emerging Researcher and Plenary Orals
• • Emerging Researcher Prize Lecture (Basic Science)
  • • Role of Obesity Gene PLXNA4 in Neurodevelopment and Anxiety

      ea0117er1.1
  • Emerging Researcher Prize Lecture (Clinical)
  • • Kisspeptin-54 accurately identifies the cause of delayed puberty

      ea0117er1.2
  • Clinical Endocrinology Journal Foundation Best Abstract (Clinical)
  • • Improved Skeletal Dynamics in Adults Treated with Palopegteriparatide for Chronic Hypoparathyroidism: 214-Week Results from the Phase 2 PaTH Forward Trial

      ea0117er1.3
  • Clinical Endocrinology Journal Foundation Best Abstract (Basic)
  • • Visualising microvascular changes in digestive organs during the onset of type 2 diabetes with super-resolution ultrasound

      ea0117er1.4
• Symposia
• • Symposium 1 – Phone a friend adrenal and NET cases
  • • Phone a friend adrenal and NET cases

      ea0117s1.1
  • Symposium 2 – Novel mechanisms in metabolic disease
  • • The fat remembers: epigenetic changes in adipose tissue in obesity

      ea0117s2.1
    • Endothelial insulin resistance induced by adrenomedullin mediates obesity-associated diabetes

      ea0117s2.2
    • Abstract unavailable

      ea0117s2.3
  • Symposium 3 – New approaches to neuroendocrine established disease
  • • Abstract unavailable

      ea0117s3.1
    • Abstract unavailable

      ea0117s3.2
    • Abstract unavailable

      ea0117s3.3
  • Symposium 4 – State of the Art in managing thyroid disease
  • • Novel treatments for managing autoimmunity in Graves' disease

      ea0117s4.1
    • Abstract unavailable

      ea0117s4.2
    • Abstract unavailable

      ea0117s4.3
  • Symposium 5 – Teaching and Outreach
  • • Abstract unavailable

      ea0117s5.1
    • Abstract unavailable

      ea0117s5.2
    • Abstract unavailable

      ea0117s5.3
  • Symposium 6 – The ovary: from physiology to pathophysiology
  • • Abstract unavailable

      ea0117s6.1
    • Luteinizing Hormone-Responsive Metabolic Signaling Regulates Luteal Steroidogenesis

      ea0117s6.2
    • Abstract unavailable

      ea0117s6.3
• Workshops
• • Basic Physiology Workshop: New targets of GLP – 1 Receptor agonists
  • • Abstract unavailable

      ea0117ws1.1
    • Glucagon-like peptide 1 receptors as targets for addiction

      ea0117ws1.2
    • Abstract unavailable

      ea0117ws1.3
  • Clinical Workshop: Make it make sense – Interpreting discordant or complex dynamic hormone results
  • • Abstract unavailable

      ea0117ws2.1
    • Abstract unavailable

      ea0117ws2.2
    • Low glucose, high stakes - investigation of spontaneous hypoglycaemia

      ea0117ws2.3
• How Do I...? Sessions
• • How do I...? 1
  • • Abstract unavailable

      ea0117hdi1.1
    • Abstract unavailable

      ea0117hdi1.2
    • Abstract unavailable

      ea0117hdi1.3
    • Abstract unavailable

      ea0117hdi1.4
    • How do I\..mainstream genomic testing from the endocrine clinic?

      ea0117hdi1.5
  • How do I...? 2
  • • How do I induce puberty in congenital hypogonadotropic hypogonadism?

      ea0117hdi2.1
    • Abstract unavailable

      ea0117hdi2.2
    • Abstract unavailable

      ea0117hdi2.3
    • Abstract unavailable

      ea0117hdi2.4
    • Building back bone and improving fracture risk - what you can do for your patients, right now

      ea0117hdi2.5
• Meet the Expert Sessions
• • Congenital Adrenal Hyperplasia
  • • Managing Congenital Adrenal Hyperplasia - Optimising Treatment Strategies

      ea0117mte1
  • Belzutifan – VHL and beyond
  • • Abstract unavailable

      ea0117mte2
  • Fertility preservation in male childhood cancer
  • • Meet the expert - fertility preservation in male childhood cancer

      ea0117mte3
  • Nurse
  • • Abstract unavailable

      ea0117mte4
  • Functional imaging in tricky pituitary cases
  • • Abstract unavailable

      ea0117mte5
  • Advances in systemic therapy for thyroid cancer
  • • Abstract unavailable

      ea0117mte6
  • Hormone and risk management across the lifespan in transgender patients
  • • Hormone and risk management across the lifespan in transgender patients

      ea0117mte7
  • Approaches to weight loss for people with obesity: Lifestyle, Surgery & Medications on quality of weight loss
  • • Abstract unavailable

      ea0117mte8.1
    • Abstract unavailable

      ea0117mte8.2
    • Abstract unavailable

      ea0117mte8.3
  • Blood and Bone
  • • Abstract unavailable

      ea0117mte9
  • Updates in diagnosis and management of POI
  • • Abstract unavailable

      ea0117mte10
  • Meet the Editor
  • • Abstract unavailable

      ea0117mte11
• Other Sessions
• • What is New?
  • • What's new in clinical endocrinology?

      ea0117win1
    • What's new in basic science research in endocrinology?

      ea0117win2
  • Cutting Edge Techniques: Trailblazing techniques driving new discoveries in endocrinology
  • • What has single cell sequencing told us about the hypothalamus?

      ea0117ce1
    • What can mass spectrometry do for endocrinologists?

      ea0117ce2
    • Abstract unavailable

      ea0117ce3
  • SfE Guidelines
  • • Abstract unavailable

      ea0117gl1
    • Review of the new (2025) ESE Guidelines on Management of Chronic Hypoparathyroidism

      ea0117gl2
• Oral Communications
• • Adrenal and Cardiovascular
  • • Replacing the early morning cortisol rise reduces fatigue and improves qol in adrenal insufficiency: a double-blind study

      ea0117oc1.1
    • Validation of prognostic biomarkers in adrenocortical carcinoma through Next-Generation Sequencing and pyrosequencing in a real-life setting

      ea0117oc1.2
    • Serum steroid metabolomics is inferior to urine steroid metabolomics in the detection of adrenocortical carcinoma

      ea0117oc1.3
    • Improved wellbeing and reduced cardiometabolic risks with once-daily low-dose prednisolone in adrenal insufficiency: interim results from the hyper-aid study

      ea0117oc1.4
    • Validating the utility of morning salivary cortisone in the assessment for adrenal insufficiency

      ea0117oc1.5
    • Childhood Androgen Excess and Metabolic Risk: A Case-Control Study in Premature Adrenarche and Adolescent Polycystic Ovary Syndrome

      ea0117oc1.6
  • Mechanisms and Management of Endocrine Disease
  • • Peri-prostatic adipose tissue drives obesity-associated prostate cancer aggressivity via extracellular vesicles and Rho GTPase signalling

      ea0117oc2.1
    • Imaging adrenal aldosterone synthase expression with [¹⁸F]AldoView PET-CT in primary aldosteronism

      ea0117oc2.2
    • Retrospective Review of the Management of Head and Neck Paragangliomas in a UK PPGL Centre of Excellence

      ea0117oc2.3
    • Sphingosine kinase 2 (SPHK2) inhibition as a therapeutic strategy for adrenocortical carcinoma (ACC)

      ea0117oc2.4
    • Rationalising the use of hypertonic saline-stimulated copeptin measurements in differentiating between AVP deficiency and primary polydipsia

      ea0117oc2.5
  • Bone and Reproductive Endocrinology
  • • Investigating fertility and reproductive ageing in a Down syndrome mouse model

      ea0117oc3.1
    • Kisspeptin challenge test reveals hypothalamic dysfunction in obesity-related hypogonadism

      ea0117oc3.2
    • Short-term oestradiol variability across HRT preparations in postmenopausal women

      ea0117oc3.3
    • DNA methylation of gonadotropin-releasing hormone regulatory genes is altered in human delayed puberty

      ea0117oc3.4
    • Improvements in Lower Extremity Alignment are Associated with Physical Functioning in Children with Achondroplasia Treated with Navepegritide: 52-Week Results from the ApproaCH Trial

      ea0117oc3.5
    • Comparative Effectiveness of Bariatric Surgery vs. Pharmacologic Weight Loss on Bone Health and Fracture Risk in Asian Population

      ea0117oc3.6
  • Thyroid
  • • Functional characterization of two different NAH-associated activating TSHR mutations

      ea0117oc4.1
    • Neutrophil count and neutropenia in newly diagnosed hyperthyroidism: ethnic variation and TRAb-Free-T4 interaction

      ea0117oc4.2
    • Development of 3D thyroid follicles from primary human and murine thyrocytes

      ea0117oc4.3
    • Evaluating levothyroxine cessation and thyroid status: a city-wide population record analysis

      ea0117oc4.4
    • Batoclimab Induces Very Rapid and Sustained Post-treatment Euthyroidism in Graves' Disease

      ea0117oc4.5
    • Mapping the mutational landscape of thyroid carcinoma using whole-exome sequencing

      ea0117oc4.6
  • Metabolism, Obesity and Diabetes
  • • Integrative multi-omics analysis reveals epigenetic regulation of placental genes associated with maternal B12 deficiency

      ea0117oc5.1
    • Identifying high-risk women after GDM: multivariate analysis of routine clinical metrics for postpartum dysglycaemia

      ea0117oc5.2
    • Beneficial effect of protein-induced glucose tolerance is independent of protein-induced insulin release

      ea0117oc5.3
    • High fracture rates in obesity despite normal bone mineral density

      ea0117oc5.4
    • A targeted epi-drug screen identifies HDAC6 inhibition as an enhancer of beta cell function and immune evasion

      ea0117oc5.5
    • Decoding the obese duodenal cell atlas

      ea0117oc5.6
  • Neuroendocrinology and Pituitary
  • • Predictive value of day-7 serum cortisol for hypothalamic-pituitary-adrenal axis recovery following transsphenoidal surgery

      ea0117oc6.1
    • Defective nitric oxide pathway signalling - a link between premature birth and altered mini-puberty?

      ea0117oc6.2
    • Charting the clinical course of immune checkpoint inhibitor-related endocrinopathies amongst 833 ICI-treated patients in north wales

      ea0117oc6.3
    • Peripartum increases in serum prolactin and differential mammary prolactin receptor isoform expression are associated with human secretory activation

      ea0117oc6.4
    • Insights into Somatostatin Analogue Response: Alterations in SSTR and Ki-67 Expression in LCC-18 Neuroendocrine Tumour Cells

      ea0117oc6.5
    • Long-term and sustained biochemical control of acromegaly and improved quality of life with CAM2029 octreotide subcutaneous depot: final analysis of the core phase of ACROINNOVA 2

      ea0117oc6.6
• Oral Poster Presentations
• • Neuroendocrinology and Pituitary
  • • Immune Checkpoint Inhibitor-Related Hypophysitis and Pituitary Dysfunction: A Systematic Review of Clinical Presentation, Diagnosis, and Management

      ea0117op1.1
    • MECP2 as a regulator of transcription and chromatin conformation in GnRH neurons: implications for puberty

      ea0117op1.2
    • HypoMap3D: a reference spatio-cellular atlas of the mouse hypothalamus for studying neuroendocrine biology and disorders

      ea0117op1.3
    • Autistic spectrum disorders and heterogenous pituitary phenotype in patients with AIP- variants

      ea0117op1.4
  • Metabolism, Obesity and Diabetes
  • • miR-10b-5p promotes brown adipocyte differentiation and the thermogenic program in white adipose tissue

      ea0117op2.1
    • Loss of 11[beta]-HSD1 attenuates skeletal muscle atrophy during glucocorticoid therapy in experimental kidney injury

      ea0117op2.2
    • Efficacy of GLP-1 Receptor Agonists in Patients with Prader-Willi Syndrome: A Retrospective Cohort Study

      ea0117op2.3
    • Biased agonism can modulate response to GLP-1R therapy through altered surface availability in the CNS

      ea0117op2.4
  • Adrenal and Cardiovascular
  • • A Role for Non-Muscle Myosin IIA in Adrenocortical Carcinoma

      ea0117op3.1
    • Redox modulation enhances the metabolic efficacy of SGLT2 inhibition

      ea0117op3.2
    • Salivary hybrid steroids and the sub-classification of primary aldosteronism: a pilot study

      ea0117op3.3
    • Weight loss induced by bariatric surgery impacts significantly on serum and urinary mineralocorticoid metabolism in men and women

      ea0117op3.4
  • Endocrine Cancer and Late Effects
  • • Computer-assisted cytopathological diagnosis in pancreatic tumours: a systematic review and meta-analysis

      ea0117op4.1
    • SGK3 and lipid remodelling: a key player in androgen-mediated metabolic dysregulation in endocrine-resistant breast cancer

      ea0117op4.2
    • Optimising glucocorticoid replacement in adrenocortical cancer: the role of ACTH monitoring

      ea0117op4.3
    • GloBE-Reg: A Global Registry for Evaluating the Safety and Effectiveness of Growth Hormone Therapy Across The Age Span

      ea0117op4.4
  • Innovation in Teaching and Assessment
  • • Postgraduate Educational Methods in Diabetes, Endocrinology and Metabolism (PEMDEM): A Systematic Review of Training Approaches and Their Impact on Clinical Competence and Patient Care

      ea0117op5.1
    • EndocrineDigiSim: A Pilot Study of Digital Endocrine Consultation Simulation for Postgraduate Medical Training

      ea0117op5.2
    • Hormone hype and health misinformation: social media marketing of cortisol and testosterone

      ea0117op5.3
    • Enhancing endocrine training through virtual simulation: addressing social determinants of health, health inequities and multiple long-term conditions

      ea0117op5.4
    • Inpatient hyponatraemia diagnosis and management

      ea0117op5.5
  • Bone and Calcium
  • • CCN family member 3 (CCN3) is a potential human osteoanabolic lactation hormone

      ea0117op6.1
    • Characterisation of human sulfotransferases involved in vitamin D metabolite sulfation and population-level variation in sulfation

      ea0117op6.2
    • An endocrine nurse led cinacalcet clinic? saving money, avoiding admissions and keeping patient safe!

      ea0117op6.3
    • Efficacy and Safety of Palopegteriparatide Treatment in Adults With Hypoparathyroidism: 3-Year Results From the Phase 3 PaTHway Trial

      ea0117op6.4
  • Reproductive Endocrinology
  • • Adaptive metabolic plasticity defends body reserves during reproduction

      ea0117op7.1
    • Low Protein Diet Alters Embryo Morphology and 1-Carbon Metabolism in Mice

      ea0117op7.2
    • A Single Centre Study to Describe the Changes in Serum Testosterone Concentration Following Application of Testosterone Gel in Post-Menopausal Women with Hypoactive Sexual Desire Disorder (HSSD) Already Receiving this as Part of Usual Care in Conjunction with Oestrogen Containing Hormone Replacement Treatment (HRT)

      ea0117op7.3
    • Disentangling the impact of obesity on reproductive, metabolic and adipokine profiles in women with or without PCOS

      ea0117op7.4
• Featured Clinical Case Posters
• • Section
  • • Macrophage polarisation and metabolic reprogramming in cortisol-producing adenomas

      ea0117cc1
    • Severe catecholamine-induced cardiomyopathy improved after adrenalectomy without surgical complications: case report

      ea0117cc2
    • CT-Guided Radiofrequency Ablation as a Novel Treatment for Adrenal Cushing's Syndrome in a High-Risk Surgical Candidate

      ea0117cc3
    • A decade of experience using mifepristone to treat 'Primary Pigmented Nodular Adrenocortical Disease' in Carney Complex'

      ea0117cc4
    • Spontaneous haemorrhage of a functioning parathyroid carcinoma presenting with refractory hypercalcaemia: a rare case report

      ea0117cc5
    • Persistent hypercalcaemia secondary to suspected silicone-induced granulomatous disease: a diagnostic challenge

      ea0117cc6
    • Post-bariatric hypoglycaemia in pregnancy: Lessons learnt from a case series

      ea0117cc7
    • Hook effect in a giant infiltrating macroprolactinoma: a diagnostic pitfall with therapeutic implications

      ea0117cc8
    • Airway emergency from acute parathyroid adenoma haemorrhage: A case presentation

      ea0117cc9
    • Thyroid nodule rupture - an uncommon complication following radiofrequency ablation

      ea0117cc10
• Poster Presentations
• • Adrenal and Cardiovascular
  • • Physiological dose tapering promotes hypothalamic-pituitary-adrenal axis recovery in glucocorticoid-induced adrenal insufficiency

      ea0117p1
    • Bridging the safety gap: implementing electronic health record alerts for patients with adrenal insufficiency

      ea0117p2
    • Steroids, suppression, and specialist care: lessons from a severe asthma cohort

      ea0117p3
    • Adrenal suppression after local steroid injection in a patient on cobicistat-based antiretroviral therapy

      ea0117p4
    • Audit of FH identification and management in a UK lipid clinic: are we meeting NICE standards CG71 and TA393?

      ea0117p5
    • Evaluation of Evening Salivary Cortisone vs 48-hour Low Dose Dexamethasone Suppression Test in the Investigation of Cushing's Syndrome

      ea0117p6
    • Adrenal adenomata displaying mild autonomous cortisol secretion:a service evaluation of cardiometabolic profile routinely screened patients

      ea0117p7
    • Once-Daily Low-Dose Prednisolone Improves Cardiometabolic Profiles in Adrenal Insufficiency Versus Multiple-Daily Dose Hydrocortisone in a Double-Blind Randomised Crossover Trial

      ea0117p8
    • Development of an LC-MS/MS assay for the measurement of urinary aldosterone and related metabolites to screen for primary aldosteronism

      ea0117p9
    • Salivary Steroids: profiling, quantification and validation using liquid chromatography triple quadrupole mass spectrometry

      ea0117p10
    • Long term medical control of ARMC5 related bilateral primary macronodular adrenal hyperplasia (BPMAH) with low-dose metyrapone

      ea0117p11
    • Validation of LC-MS-based post-saline infusion test aldosterone thresholds for the diagnosis of primary aldosteronism

      ea0117p12
    • Streamlining the management of adrenal incidentalomas: a retrospective audit and service improvement initiative

      ea0117p13
    • [ldquo]From collapse to control: pyridostigmine for postural hypotension in abiraterone-related adrenal insufficiency[rdquo]

      ea0117p14
    • Beyond the 50 nmol/l cut-off: improving 1 mg-overnight dexamethasone suppression test accuracy with assay-specific thresholds

      ea0117p15
    • Failed surgery, failed theranostic, failing-functioning: any more evidenced-based therapeutic options in a 67year old man with multicentric locally aggressive familial sdhbparaganglioma

      ea0117p16
    • Prolonged surgery and complex perioperative management in a patient with a large cerebellopontine angle paraganglioma

      ea0117p17
    • A retrospective evaluation of desmopressin prescribing for the management of AVP-D and AVP-R

      ea0117p18
    • The Diagnostic puzzle of adrenal schwannomas- a rare case presentation

      ea0117p19
    • Adrenal Venous Sampling at King's College Hospital, London - an audit of the current practice

      ea0117p20
    • Streamlining the Adrenal MDT Pathway: A Quality Improvement Project to Optimise Diagnostic Workflow and Resource Utilisation at Birmingham Heartlands Hospital

      ea0117p21
    • Do variants in the AIRE (autoimmune regulator) gene contribute to regular autoimmune addison's disease susceptibility?

      ea0117p22
    • GTN-induced pheochromocytoma crisis: a rare but important clinical lesson

      ea0117p23
    • Loss of glucocorticoid receptor signalling causes a primary cilia defect in the fetal mouse kidney

      ea0117p24
    • Hypoglycaemia as a presentation of advanced adrenal cortical carcinoma, two case reports

      ea0117p25
    • The role of cortisol and aldosterone in hypertensive nephropathy

      ea0117p26
    • Adrenal insufficiency in pregnant population: a diagnostic challenge

      ea0117p27
    • Mainstream genetic testing in the general adult endocrine clinic: pathogenic variants were detected in 21% of cases seen

      ea0117p28
    • Too much of a good thing: an interesting case of resistant hypokalaemia and hypertension due chronic liquorice ingestion mimicking apparent mineralocorticoid syndrome

      ea0117p29
    • Acute ACTH deficiency from high dose Quetiapine: a cautionary tale

      ea0117p30
    • Modelling human adrenocortical tumours in a 3D organoid system

      ea0117p31
    • Systemic effects of targeted-release budesonide in patients with IgA nephropathy

      ea0117p32
    • Prolonged adrenal insufficiency after withdrawal of osilodrostat: a case report and literature review

      ea0117p33
    • Overt Cushing's Disease in the ICU: Key Considerations and Challenges

      ea0117p34
    • Review of adrenal vein sampling in hypercortisolaemia and hyperandrogenaemia

      ea0117p35
    • Accessory renal artery stenosis: an incidental finding or a cause of hypertension?

      ea0117p36
    • Characterisation of MRAP and MC2R missense variants leading to familial glucocorticoid deficiency (FGD)

      ea0117p37
    • Does red hair lessen the frequency of pigmentation as a presenting feature of Addison's disease - implications for diagnosis

      ea0117p38
    • ACTH stimulation testing is often unnecessary after appropriate patient preparation prior to cortisol screening

      ea0117p39
    • Uncommon Presentation of Pheochromocytoma: Cortisol Co-secretion with Adrenal Cortical Hyperplasia

      ea0117p40
    • The Impact of Acute Exercise on Arterial Stiffness and Blood Pressure Regulation in Polycystic Ovary Syndrome (PCOS)

      ea0117p41
    • Clinical spectrum and aetiological distribution of profound hyponatraemia (Na <120 mmol/l) in a tertiary UK centre

      ea0117p42
    • An uncommon presentation of Cushing's syndrome secondary to ectopic ACTH production in metastatic prostrate carcinoma

      ea0117p43
    • A retrospective study to validate the utility of random cortisol screening to reduce the need for short Synacthen tests in secondary care

      ea0117p44
    • Adrenal Cushing's Syndrome in Twin Pregnancy: A Rare Presentation with Atraumatic Femoral Neck Fracture and Severe Fetal Growth Restriction

      ea0117p45
    • Urine steroid profiles: to pee or not to pee?

      ea0117p46
    • Secondary Hypoaldosteronism - Post-Adrenalectomy Sequelae for Conn's Syndrome

      ea0117p47
    • The HISTAR score: integrating CYP11B2 immunohistochemistry with clinical predictors to improve clinical cure prediction after adrenalectomy in primary aldosteronism - a pilot study

      ea0117p48
    • Steroid metabolome profiling in chronic kidney disease

      ea0117p49
    • An unusual cause of nocturnal hyperglycaemia

      ea0117p50
    • The screening yield for phaeochromocytomas and paragangliomas from hypertension clinic is low with a significant false positive rate

      ea0117p51
    • Case Series of Three Distinct Clinical Paths for Recurrent Pheochromocytoma / Paraganglioma (PPGLs) Managed at University Hospitals Derby & Burton NHS Trust in Collaboration with Regional Neuroendocrine Tumour (NET) MDTs

      ea0117p52
    • Variation in serum cortisol thresholds and use of salivary cortisol/cortisone in the biochemical diagnosis of adrenal insufficiency (AI) in the UK: Results from the Society for Endocrinology survey

      ea0117p53
    • Shallow Whole-Genome Sequencing of Cell-Free DNA for Copy Number Analysis in Adrenocortical Carcinoma Monitoring

      ea0117p54
  • Bone and Calcium
  • • A case of McCune-Albright Syndrome - the importance of a multidisciplinary approach and symptom-focused management

      ea0117p55
    • When calcium tells a deeper story: a case of atypical parathyroid adenoma with malignant features

      ea0117p56
    • Long-Term Efficacy and Safety of Palopegteriparatide Treatment in Adults With Chronic Hypoparathyroidism: 4-Year Results From the Phase 2 PaTH Forward Trial

      ea0117p57
    • Primary hyperparathyroidism in pregnancy: two case reports

      ea0117p58
    • FGF-23-driven hypophosphatemia: a rare puzzle in clinical practice

      ea0117p59
    • A rare case of hypocalcaemia - diagnosis and therapeutic delima

      ea0117p60
    • Clinical utility of urinary calcium-creatinine clearance ratio (UCCCR) and calcium excretion index (CEI) in the diagnosis and management of primary hyperparathyroidism (PHPT): a single-centre audit

      ea0117p61
    • Referral accuracy of romosozumab candidates: lessons from an expedited fracture liaison service pathway

      ea0117p62
    • A case report of symptomatic hypercalcemia in familial hypocalciuric hypercalcemia

      ea0117p63
    • GCM2 Activation association with hyperparathyroidism and oncogenic potential

      ea0117p64
    • Incomplete bone density normalisation following long-term reproductive hormone treatment in male hypogonadotropic hypogonadism: a systematic review and meta-analysis

      ea0117p65
    • Our experience with intraoperative PTH measurement (IOPTH) during the initial surgery for primary hyperparathyroidism (PHPT): data on 250 patients

      ea0117p66
    • Comparative analysis of ultrasound, SPECT-MIBI, and co-registered CT concordance with surgical outcomes in parathyroid adenomas

      ea0117p67
    • A tanned clue: severe hypercalcaemia and multisystem involvement unmasking underlying diagnosis

      ea0117p68
    • Metachronous presentation of hypercalcaemia with Graves' hyperthyroidism followed by primary hyperparathyroidism: random occurrence or is there an association?

      ea0117p69
    • Longitudinal biochemical trends following parathyroidectomy for primary hyperparathyroidism: a single-centre experience from University Hospitals Birmingham

      ea0117p70
    • Identifying an androgen-bone axis across reproductive-endocrine states

      ea0117p71
    • Parathyroid bone disease in the medical management of primary hyperparathyroidism

      ea0117p72
    • Somatostatin analogue induced-recalcitrant hypocalcaemia in post-surgical hypoparathyroidism

      ea0117p73
    • Missed opportunities in hypercalcaemic stone formers: detecting primary hyperparathyroidism

      ea0117p74
    • What's the highest calcium you have ever seen? A case of profound hypercalcaemia causing irreversible end stage renal disease

      ea0117p75
    • Successful treatment of tumour-induced osteomalacia with CT guided radiofrequency ablation

      ea0117p76
    • Optimising referral for FHH: the role of CCCR thresholds and clinical confounders

      ea0117p77
    • Efficacy of Recombinant Human Parathyroid Hormone (rhPTH 1-84, Natpar) in Patients with Treatment-Resistant Chronic Hypoparathyroidism

      ea0117p78
    • Hypophosphatasia: the hidden diagnosis behind persistently low alkaline phosphatase: case report

      ea0117p79
    • A rare case of hypocalcemia due to a genetic form of isolated hypoparathyroidism

      ea0117p80
    • From longstanding hypercalcaemia to spontaneous normocalcaemia: parathyroid auto-infarction or alternative mechanisms?

      ea0117p81
    • An audit of management of Vertebral Fractures detected and reported from lateral CXR using AI technology in a tertiary Oncology centre

      ea0117p82
  • Endocrine Cancer and Late Effects
  • • Audit of adrenal biopsies at a large tertiary referral centre: a decade of improving outcomes

      ea0117p83
    • Epigenetic characterisation of canine insulinoma: a comparative model for human disease

      ea0117p84
    • Mapping the endocrine impact of immunotherapy: a retrospective audit and future service implications

      ea0117p85
    • Oesophageal neuroendocrine tumour masquerading as small cell oesophageal carcinoma: a case series of conundrums

      ea0117p86
    • RAD-PIT: Novel PPIE-driven protocol co-design for the use of Macimorelin as a diagnostic test of pituitary function for patients undergoing proton and photon radiotherapy

      ea0117p87
    • A metastatic pulmonary neuroendocrine tumour presenting as wisdom tooth pain

      ea0117p88
    • Adrenocortical Carcinoma in Lynch Syndrome - an oft-forgotten marriage

      ea0117p89
    • Selective internal radiation therapy (SIRT) for stage IV adrenal cortical cancer: a case report and review of the literature

      ea0117p90
    • Androgen steroidogenesis and functional effect in mucinous ovarian cancer cells, organoids and patient tumours

      ea0117p91
    • RNA-seq analysis of transcriptional co-regulators of NIS in a murine model of triple negative breast cancer

      ea0117p92
    • ccfDNA concentrations in adrenal pheochromocytoma and other adrenal tumours

      ea0117p93
    • From audit to action: standardising care for the immune-related endocrinopathies of immune checkpoint inhibitor therapy

      ea0117p94
  • Metabolism, Obesity and Diabetes
  • • Anti-diabetic activity of ethanolic fractions of Cocos nucifera (coconut) husk in streptozotocin-induced gestational diabetes: an in vivo study

      ea0117p95
    • Benefits of Wegovy independent of weight loss in a patient with hypertrophic cardiomyopathy and obesity

      ea0117p96
    • Pickwickian Syndrome: Semaglutide, Weight Loss, and Resolution

      ea0117p97
    • The possibilities of using flash glucose monitoring in a hospital

      ea0117p98
    • Macrophage glucocorticoid metabolism as a therapeutic target to improve muscle regeneration

      ea0117p99
    • Developing a fluorescent reporter system for scalable detection of PYY production from enteroendocrine cells in real time with single-event resolution

      ea0117p100
    • Flavonoids from Hunteria umbellata Seeds Mitigate Diabetic Nephropathy in Streptozotocin-Induced Rats

      ea0117p101
    • Trajectory of weight regain after cessation of glucagon-like-peptide-1 receptor agonists: a systematic review and nonlinear meta-regression

      ea0117p102
    • Consistency of basal insulin prescription and rate of insulin reduction during DKA therapy to prevent rebound ketosis and hypoglycemia during therapy- a retrospective audit of the management of diabetes ketoacidosis against JBDS standards

      ea0117p103
    • Severe hypertriglyceridemia in pregnancy: diagnostic delay, therapeutic challenges, and unanswered questions

      ea0117p104
    • Latent autoimmune diabetes in a young male - a case report

      ea0117p105
    • Proof of concept audit looking at the potential for opportunistic intervention to improve glycaemic control and process of care measures in acute hospital admissions in patients with diabetes

      ea0117p106
    • Vamorolone attenuates 11[beta]-HSD1 induction and catabolic signalling in human skeletal muscle under inflammatory conditions

      ea0117p107
    • Utilising untargeted metabolomics as a tool to dissect dysfunctional skeletal muscle lipid metabolism in men with hypogonadism: results from a metabolic phenotyping study

      ea0117p108
    • Symptomatic hypoglycemia in end-stage renal disease - diagnostic pitfalls and challenges in management

      ea0117p109
    • Investigating the role of direct neuronal innervation of the pancreas by the stomach

      ea0117p110
    • Real world outcomes of adjunctive sodium-glucose cotransporter-2 (SGLT2) inhibitors in adults with type 1 diabetes: a single-centre retrospective analysis

      ea0117p111
    • Dual GLP-1 and GIP therapy for severe post-bariatric surgery hypoglycaemia: a clinical case

      ea0117p112
    • Association between hepatic steatosis and vitamin D insufficiency in nonalcoholic fatty liver disease patients

      ea0117p113
    • Long-term LDL-C reduction and treatment persistence with PCSK9 inhibitors: a real-world evaluation from a secondary care lipid service

      ea0117p114
    • Cardiovascular Risk Assessment Tools in Type 2 Diabetes Mellitus: A Comparative Study from Nigeria

      ea0117p115
    • Chronic GIPR agonism results in human beta cell GIPR desensitisation

      ea0117p116
    • Maternal incretin hormones can predict insulin resistance in pregnant women

      ea0117p117
    • A case of new onset type 2 DM presenting with DKA in 85-year-old female on immunotherapy for multiple myeloma

      ea0117p118
    • Comparative efficacy of GLP-1 RA vs. SGLT2 inhibitors in slowing chronic kidney disease (CKD) progression - a retrospective study done in northern hospital in pakistan

      ea0117p119
    • DKA: diagnostic conundrums of a common presentation on take

      ea0117p120
    • Metabolic-bariatric surgery outcomes in people with pre-surgical mental health diagnoses

      ea0117p121
    • Human genetic determinants of skeletal muscle and adipose tissue partitioning

      ea0117p122
    • Exaggerated GLP-1 and satiety responses after gastrectomy: implications for metabolic adaptation

      ea0117p123
    • Indole-3-carbinol stimulates GLP-1 release and improves glucose tolerance

      ea0117p124
    • Autosplenectomy in a patient with autoimmune polyglandular syndrome type 2 (APS-2)

      ea0117p125
    • Reactive hypoglycaemia following fundoplication surgery for hiatus hernia successfully treated with GLP1 agonists

      ea0117p126
    • Insulin Antibody Syndrome (Hirata's Disease) in a young female

      ea0117p127
    • Cholecystokinin and secretin differentially regulate glucose homeostasis

      ea0117p128
    • Small intestinal integrity contributes to glucose homeostasis

      ea0117p129
    • Utilising urine as a non-invasive biofluid to assess type 2 diabetes and predict metabolic improvement with bariatric surgery

      ea0117p130
    • Steroid 5[alpha]-reductase network in metabolic dysfunction-associated steatotic liver disease

      ea0117p131
    • Hyponatraemia at st george's hospital

      ea0117p132
    • The Tubby Protein as a Transcription Factor Regulating Brown Adipocyte Differentiation

      ea0117p133
    • When hypoglycemia hits early: a rare case of insulinoma post-bariatric surgery and novel tirzepatide therapy in preoperative optimization

      ea0117p134
    • Alcohol abuse: an easily missed cause of severe lactic acidosis

      ea0117p135
    • Glucocorticoid activation of mono-ADP-ribosylation through parp16 determines er stress response

      ea0117p136
    • Delayed diagnosis of Wolfram Syndrome Type I Spectrum Disorder

      ea0117p137
    • Three similar cases of misdiagnosed glycogenic hepatopathy - a cautionary tale

      ea0117p138
    • Exploring brown adipose tissue-mediated systemic metabolism using network analysis of total-body PET/CT scans

      ea0117p139
    • Development of sub-clinical hepatic steatosis precedes metabolic dysfunction but not obesity in a porcine model of high-fat feeding

      ea0117p140
    • Insulin Autoimmune Syndrome: Presenting as severe hypoglycemia with recurrent syncope and seizures

      ea0117p141
    • High-throughput functional screening of INSR intracellular domain variants

      ea0117p142
    • Insulinotropic and metabolic benefits of Punica granatum peel extract in obese diabetic mice

      ea0117p143
    • Euglycaemic diabetic ketoacidosis associated with semaglutide use: a case report

      ea0117p144
    • An audit on outpatient insulin prescribing practice in an Irish tertiary hospital

      ea0117p145
    • G protein-coupled oestrogen receptor 1 regulates CPT1a expression in human hepatocytes

      ea0117p146
    • Deep metabolic phenotyping reveals tissue-specific actions of transdermal oestradiol and oral micronised progesterone in postmenopausal women

      ea0117p147
    • Long-Term Impact of Roux-en-Y Gastric Bypass on Comorbidity and Type 2 Diabetes in Adolescents: A Systematic Review and Meta-Analysis

      ea0117p148
    • Use of fibroscan assessment to determine MASLD in a diverse paediatric obesity cohort

      ea0117p149
    • Real-World Experience of Semaglutide (Wegovy) Effectiveness in Weight Loss in an NHS Tier-3 Weight Management Service

      ea0117p150
    • Successful outpatient treatment of diabetic foot osteomyelitis with dalbavancin - a case report

      ea0117p151
    • Evaluating adherence to lipid management guidelines in adults with type 1 diabetes: a clinical audit of primary prevention practices

      ea0117p152
    • The pharmacology of biased anorectic gut hormone-derived treatments

      ea0117p153
    • The efficiency of point-of-care blood ketone monitoring in a central London hospital

      ea0117p154
    • Reversing obesity-induced type 2 diabetes in the NONcNZO10/ltJ polygenic mouse model: a multi-omics perspective from the liver

      ea0117p155
    • IgG4-related disease presenting with new-onset diabetes

      ea0117p156
    • Modelling Biased Agonism at the GLP-1R Using C-terminal Modifications

      ea0117p157
    • Transcranial super-resolution ultrasound imaging as a tool to visualise neuronal activation patterns in the brain following peripheral administration of GLP-1 receptor agonists

      ea0117p158
    • Triglyceride-glucose (tyg) index cut-off for identifying metabolic syndrome in nigerians

      ea0117p159
    • Factors impacting hospital length of stay in older adults on insulin: a single-centre observational study

      ea0117p160
    • Protective Role Of Garcinia Kola Against Cadmium Chloride-Induced Pancreatic Dysfunction And [beta]-Cell Apoptosis In Wistar Rats

      ea0117p161
    • Case series on patients with post bariatric reactive hypoglycaemia followed up in Medical Obesity Clinic at Princess Royal University Hospital

      ea0117p162
  • Neuroendocrinology and Pituitary
  • • Sellar extraventricular neurocytoma: the great pituitary adenoma mimic

      ea0117p163
    • CNS relapse of diffuse large B-cell lymphoma presenting with panhypopituitarism and diabetes insipidus: a case report

      ea0117p164
    • Syndrome of inappropriate antidiuresis (SIAD) secondary to high-grade neuroendocrine prostate cancer (NEPC): a rare presentation

      ea0117p165
    • Acromegaly - a single centre retrospective analysis of outcomes post radiotherapy

      ea0117p166
    • Histological and biochemical analysis of pituitary surgeries performed over a decade

      ea0117p167
    • Diagnostic pitfalls in endogenous hyperinsulinemia hypoglycemia: a rare case of insulin autoimmune syndrome

      ea0117p168
    • Hypophysitis masquerading as pituitary macroadenoma: clinical diagnostic challenge

      ea0117p169
    • Evaluation of 1.8% Hypertonic Saline Use in Acute Severe Hyponatraemia: An Audit of Patients Admitted to a Medical High Dependency Unit

      ea0117p170
    • Osilodrostat therapy and 11C-methionine PET to IMprove corticotroph pituitary Adenoma detection and Localisation in patients with Cushing's disease (OPTIMAL); study design and rationale

      ea0117p171
    • Rivaroxaban Prophylaxis for VTE Prevention in ACTH-Dependent Cushing's Syndrome: Safety and Effectiveness in a Single-Centre Retrospective Cohort

      ea0117p172
    • A rare case of isolated ACTH deficiency (IAD) following COVID

      ea0117p173
    • A rare case of triple endocrine dysfunction following immune checkpoint inhibitor therapy

      ea0117p174
    • Unmasking of Idiopathic Parkinson's Disease (PD) following cessation of Cabergoline in a patient with Macroprolactinoma

      ea0117p175
    • A rare case of ectopic ACTH production and carcinoid syndrome from a metastasized small bowel neuroendocrine tumour

      ea0117p176
    • A case of insulinoma in an elderly man: diagnostic and treatment challenges

      ea0117p177
    • Secondary hypogonadism in adulthood: late presentation of congenital obstructive hydrocephalus with pituitary stalk distortion

      ea0117p178
    • Development of hypopituitarism after fractionated pituitary radiotherapy for pituitary disease: a single-centre audit

      ea0117p179
    • Ectopic ACTH-producing pulmonary carcinoid tumor presenting with cushing syndrome

      ea0117p180
    • Breast cancer and Venous Thromboembolic disease (VTE) in patients with Multiple Endocrine Neoplasia type 1 (MEN 1) in The Sheffield NET Centre, European Neuroendocrine Centre of Excellence

      ea0117p181
    • Outcomes of hospitalized patients with severe hyponatremia: findings from the pilot of HypoNa-RESCUE, a multicentre observational study

      ea0117p182
    • Reversible central adrenal insufficiency in a patient with high dose loperamide use post bowel surgery

      ea0117p183
    • Hypertonic saline test: a salty journey from a 'feared' procedure to a safe, effective diagnostic for arginine vasopressin deficiency

      ea0117p184
    • Involvement of GM3 gangliosides in acromegaly associated insulin resistance

      ea0117p185
    • Spindle cell oncocytoma presenting with mass effect and panhypopituitarism. a case report

      ea0117p186
    • Haplotypes for disease-causing aip variants are geographically spread across the UK and ireland, but do not influence disease severity

      ea0117p187
    • The challenges of a rapidly progressive pituitary metastasis

      ea0117p188
    • Acromegaly management and outcomes: a 47-year single-centre experience

      ea0117p189
    • Inflammatory pituitary mass in a young female, treated as pituitary abscess caused by cutibacterium acnes

      ea0117p190
    • CAM2029 octreotide subcutaneous depot maintains control of IGF-I and symptoms of acromegaly across a 4-week dosing interval and for intervals greater than 28 days: data from the ACROINNOVA 1 trial

      ea0117p191
    • Lost to follow-up: the challenge of managing a treatment-resistant giant prolactinoma

      ea0117p192
    • Primary pituitary lymphoma in a patient with C1 esterase inhibitor deficiency and MGUS: a diagnostic challenge

      ea0117p193
    • Rare AIP exon 2-3 large deletion linking acromegaly and thyroid carcinoma: first case series from Albania

      ea0117p194
    • The role of Sox11 in hypothalamic-pituitary development and the pathogenesis of hypogonadotropic hypogonadism

      ea0117p195
    • Drug induced liver injury following low-dose tolvaptan for SIADH: a rare adverse event prompting a change in monitoring

      ea0117p196
    • Cushing-like but not Cushing Disease

      ea0117p197
    • When suppression stimulates: persistent testosterone elevation from gonadotrophin-releasing hormone agonist therapy in prostate cancer

      ea0117p198
    • Audit of testing for growth hormone deficiency (GHD) in teenage and young adults (TYA) and adults previously treated with cranial radiotherapy at a Tertiary Oncology Hospital

      ea0117p199
    • Case report: pharmacological and non-pharmacological therapies in the management of refractory hypoglycaemia secondary to malignant insulinoma

      ea0117p200
    • Parotid gland tumours in acromegaly: rare coincidence or IGF-related association?

      ea0117p201
    • Peptide receptor radionuclide therapy (PRRT) as a treatment option in metastatic ovarian neuroendocrine tumour with carcinoid syndrome and treated carcinoid heart disease: a case report

      ea0117p202
  • Nursing Practice
  • • Safe prescription frequency for steroids and other vital medications

      ea0117p203
  • Reproductive Endocrinology
  • • Hematological, hormonal and immunomodulatory activities of aqueous extract of Solanum nigrum (Linn.) leaf on Plasmodium bergei NK65 Infection in gravid mice: a focus on Placental malaria

      ea0117p204
    • A Retrospective Review of Functional Hypothalamic Amenorrhoea in the University Hospitals of Leicester Endocrine clinic

      ea0117p205
    • Research priorities for Polycystic Ovary Syndrome: results of a James Lind Alliance priority setting partnership

      ea0117p206
    • Prokinectin receptor 2 (PROKR2) gene mutation in a man with primary hypogonadism

      ea0117p207
    • Kisspeptin best distinguishes polycystic ovary syndrome (PCOS) from functional hypothalamic amenorrhoea (FHA) in lean women with oligo/amenorrhoea without hyperandrogenism

      ea0117p208
    • Case report - severe hyperandrogenaemia in a post-menopausal female

      ea0117p209
    • Identification of highly discriminatory serum markers able to identify undisclosed androgen abuse in men who self-report androgen cessation: a prospective, community-dwelling study

      ea0117p210
    • The psychological challenges and available resources for patients with Turner Syndrome (TS); are we meeting International Recommendations and our patients' needs?

      ea0117p211
    • Circulating leptin levels are higher in lean women with polycystic ovary syndrome than in those with hypothalamic amenorrhoea

      ea0117p212
    • Investigating the effect of anabolic-androgenic steroids on the female reproductive system: a cross- sectional study

      ea0117p213
    • Immunotherapy induced fluctuations in sex hormone levels or a perimenopausal phenomenon?

      ea0117p214
    • Mapping the biomechanical landscape of the ageing murine ovary using atomic force microscopy

      ea0117p215
    • Bilateral Leydig cell tumours in a post-menopausal woman presenting with alopecia

      ea0117p216
    • A successful case of obesity pharmacotherapy reversing male infertility recovery

      ea0117p217
  • Thyroid
  • • Just in case calcium: a novel strategy to reduce emergency department presentation due to hypocalcaemia following thyroidectomy and parathyroidectomy

      ea0117p218
    • Audit of thyroid U-classification and subsequent fine needle aspiration cytology

      ea0117p219
    • Coexistence of Resistance to Thyroid Hormone and Graves' Disease

      ea0117p220
    • The Hyperthyroid Puzzle: Coexisting Graves' Disease and a Toxic Thyroid Adenoma

      ea0117p221
    • Unmasking pembrolizumab-induced hypothyroidism in a complex multimorbid renal tumour patient: a case report

      ea0117p222
    • Graves' disease: prospective 10 year outcomes for 100 consecutive individuals at a single centre

      ea0117p223
    • The change in thyroid hormone profile pre- and post- initiation of levothyroxine: an evaluation of longitudinal thyroid hormone profile over time

      ea0117p224
    • Spontaneous normalisation of thyroid hormones in Graves' hyperthyroidism

      ea0117p225
    • Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) in endocrine crisis

      ea0117p226
    • Immune checkpoint inhibitor-induced thyroiditis in a patient on amiodarone

      ea0117p227
    • Retrospective audit on the management of amiodarone-induced thyroid dysfunction

      ea0117p228
    • From hypothyroidism to thyrotoxicosis: a case of Thyroid peroxidase-related dyshormonogenesis complicated by autoimmune Graves' disease[rdquo]

      ea0117p229
    • Acute neurological presentation of Graves' hyperthyroidism

      ea0117p230
    • Evaluating the link between thyroid function test (TFT) results and levothyroxine dose in the management of hypothyroidism: can we improve dosing regimes?

      ea0117p231
    • The change in thyroid hormone profile pre- and post- initiation of levothyroxine: an evaluation of longitudinal thyroid hormone profile over time

      ea0117p232
    • Toxic thyroid nodule initially misdiagnosed as secondary hypothyroidism

      ea0117p233
    • Thyroid dysfunction is frequently screened for but rarely identified in rapid access cardiology services

      ea0117p234
    • Self-examination saves lives - the curious case of a theatre nurse

      ea0117p235
    • Immune checkpoint inhibitor-induced thyroid dysfunction in patients with pre-existing hypothyroidism: a case series

      ea0117p236
    • Carbimazole-induced hepatotoxicity: two cases emphasising early recognition and management

      ea0117p237
    • Cardiac tamponade, abdominal ascites and pleural effusion in newly diagnosed severe hypothyroidism

      ea0117p238
    • A case of thyrotoxicosis and hypercalcemia in a patient with thyroidectomy

      ea0117p239
    • Mind the meal: getting levothyroxine timing right on the wards

      ea0117p240
    • A patient with persistent thyrotoxicosis; our experience and our hypothesis

      ea0117p241
    • Dual Autoimmunity: Myasthenia Gravis and Graves' Disease

      ea0117p242
    • A case of Severe Mitral regurgitation caused by Thyrotoxicosis in longstanding uncontrolled Grave's disease, requiring urgent inpatient thyroidectomy

      ea0117p243
    • Thyroid eye disease in euthyroid and hypothyroid patients; a single tertiary center experience

      ea0117p244
    • Evaluation of diagnostic and early management practices in anaplastic thyroid cancer

      ea0117p245
    • Don't forget the 'eye' in thyroid: a multi centre national audit reviewing endocrinologist assessment and management of thyroid eye disease in UK

      ea0117p246
    • A new national rare thyroid disease service enables early diagnosis and management of rare forms of thyroid disease

      ea0117p247
    • Patient-level drivers of increased levothyroxine (LT4) prescribing: an analysis of greater manchester population health records (2010-2024)

      ea0117p248
    • Thyroid eye disease: implementation of a standardised protocol in an irish tertiary endocrinology unit

      ea0117p249
    • TSHoma in hypothyroidism: diagnostic and therapeutic challenges

      ea0117p250
    • Weekend crisis: a repatriated patient with myxoedema coma

      ea0117p251
  • Innovation in Teaching and Assessment
  • • Integrating Endocrinology and Genetics: Reflections from the First Year of a Joint Specialty Clinic at the University Hospitals of Leicester

      ea0117p252
    • Enhancing transition from paediatric to adult endocrine care: a prospective study of patient experience and intervention feasibility

      ea0117p253
    • Optimising Nebido® prescribing and documentation in a tertiary endocrine day-unit: a quality improvement project

      ea0117p254
    • Nurses as Health Evangelists: Nurse-led Community diabetes champions Innovation in teaching program first time in Pakistan leading to Nurses' brand value elevation

      ea0117p255
  • Late Breaking
  • • Implementation of a Longitudinal Cohort to Analyse the Health Status of Adults with Congenital Adrenal Hyperplasia (CaHASE2)

      ea0117p256
    • Androgen and glucocorticoid receptor activation is co-regulated via tissue-specific metabolism by 11[beta]-hydroxysteroid dehydrogenases

      ea0117p257
    • Modified-release hydrocortisone (Efmody) in congenital adrenal hyperplasia: real-world outcomes from a tertiary endocrine service in the UK

      ea0117p258
    • Single centre experience of managing primary hyperaldosteronism

      ea0117p259
    • Romosozumab in routine clinical practice: real-world experience from a single tertiary centre

      ea0117p260
    • The [ldquo]SALAMA-D[rdquo]: a prospective oman cohort study on vitamin D status

      ea0117p261
    • A systematic review and network meta analysis of pharmacological approaches to enhance bone mineral density in functional hypothalamic amenorrhoea

      ea0117p262
    • A rare case of hypercalcaemia in pregnancy not related to primary hyperparathyroidism: the importance of a carefully orchestrated multidisciplinary approach

      ea0117p263
    • Management of florid primary hyperparathyroidism: a rare case of life-threatening hypercalcemia with a palpable parathyroid adenoma and bilateral nephrocalcinosis, requiring urgent inpatient parathyroidectomy

      ea0117p264
    • Severe hypomagnesaemia and hypocalcaemia with secondary hypoparathyroidism induced by long-term proton pump inhibitor use

      ea0117p265
    • [ldquo]It must be normocalcaemic hyperparathyroidism![rdquo] Diagnostic pitfalls of the PTH assay

      ea0117p266
    • Accelerated multidisciplinary management of primary hyperparathyroidism in pregnancy through a one stop specialist pathway

      ea0117p267
    • Adalimumab-induced hypophosphataemia: an unknown adverse effect

      ea0117p268
    • Navigating the diagnostic dilemmas of hypercalcemia in pregnancy

      ea0117p269
    • Beyond primary hyperparathyroidism: exploring physiologic PTH dynamics

      ea0117p270
    • Immune check point inhibitors induced autoimmune diabetes

      ea0117p271
    • The effect of Semaglutide (Wegovy) in patients with genetic variants linked to obesity

      ea0117p272
    • High-resolution HPLC-ESI-MS profiling of bile acids and key precursors in human plasma and faeces: a translational tool for endocrine-metabolic phenotyping

      ea0117p273
    • Improving the assessment and recording of body mass index (BMI) in adult inpatients to improve identification of obesity: a quality improvement project

      ea0117p274
    • Metabolic and diabetic phenotype of patients admitted with diabetic foot attack in the West of Scotland

      ea0117p275
    • Impact of three edible green leafy vegetables on serum lipid profile and reproductive hormones in hyperlipidemic wistar rats

      ea0117p276
    • Improving safe insulin use and management of hypoglycaemia in diabetic patients- an endocrinology-led quality improvement project

      ea0117p277
    • HDAC5 overexpression induces skeletal muscle atrophy via autophagy-lysosome pathway activation, despite enhanced protein synthesis in mice

      ea0117p278
    • Prevalence of fatty liver among diabetes vs non diabetes population with obesity awaiting bariatric surgery- a tertiary care center experience in Sri Lanka

      ea0117p279
    • Metabolic threat, obesity identification, and diabetes perception gaps among nurses: first national research survey in Pakistan

      ea0117p280
    • A case report illustrating the limited sensitivity of the oral glucose tolerance test (OGTT) in pregnancies following bariatric surgery

      ea0117p281
    • When enough may not be enough: a case of hyperhomocysteinemia

      ea0117p282
    • Virtual follow-ups: are these impacting the quality-of-care patients with diabetes mellitus receive? an audit

      ea0117p283
    • Diagnostic delay: pulmonary cryptococcus masking an ACTH-secreting pulmonary carcinoid

      ea0117p284
    • Safety and tolerability of SGLT2 inhibitor in patients with arginine-vasopressin deficiency

      ea0117p285
    • Effectiveness of new generation incretin-based therapies in hypothalamic obesity: a single centre real-world experience

      ea0117p286
    • Clinical outcomes following supply-driven transition from intranasal to oral desmopressin in AVP-deficiency- a single centre experience

      ea0117p287
    • Silent corticotroph adenomas - experience at a single pituitary centre

      ea0117p288
    • Sheehan's syndrome without massive haemorrhage: importance of recognising subtle postpartum hypopituitarism

      ea0117p289
    • An atypical presentation of a giant prolactinoma with temporal lobe oedema and seizure: a case report

      ea0117p290
    • Evolving multisystem immune-related adverse events after pembrolizumab

      ea0117p291
    • Insulinoma arising from ectopic pancreatic tissue: a rare hepatic presentation of functional metastatic NET causing hypoglycaemia

      ea0117p292
    • Predicting the long-term outcome of pituitary tumours revisiting the histopathology

      ea0117p293
    • Central diabetes insipidus in association with SARS-CoV-2 infection: a rare postinfectious pituitary complication

      ea0117p294
    • Idiopathic lymphocytic hypophysitis presenting with isolated AVP deficiency in a woman of non-reproductive age group

      ea0117p295
    • Atezolizumab-associated isolated ACTH deficiency with concomitant primary hypothyroidism

      ea0117p296
    • Gonadotroph pituitary adenoma presenting with pituitary apoplexy and cranial nerve palsies: a case report

      ea0117p297
    • From palpitations to phaeochromocytoma: a case report

      ea0117p298
    • Personalised Sick-Day Care Plan in Addison's Disease: Improving Self-Management in a Patient with Functional Dissociative Seizures

      ea0117p299
    • Revolutionizing nurse education: a national reforming model for teaching metabolic and diabetes literacy through evidence-based nurse-led diabetes care curriculum first time in Pakistan

      ea0117p300
    • A rare case of normosmic hypogonadotropic hypogonadism secondary to a genetic loss-of-function variant in TBX3

      ea0117p301
    • [ldquo]A clearer view?[rdquo] TED improvements after total thyroidectomy despite unhelpful TRAb clues

      ea0117p302
    • When the spine speaks first: a rare case of thyroid cancer presenting with cord compression

      ea0117p303
    • An audit of the follow-up and management of hypothyroidism in patients with benign thyroid disease treated with radioactive iodine - a trust experience

      ea0117p304
    • Apparent androgen excess in a hyperthyroid male: the role of sex hormone-binding globulin (SHBG) mediated hypertestosteronaemia

      ea0117p305
    • An Unusual Presentation of Graves' Disease: Thyrotoxic Myopathy

      ea0117p306
    • Type 2 amiodarone-induced thyrotoxicosis in a patient with atrial fibrillation: a case report

      ea0117p307
    • Respiratory-led presentation of a retrosternal multinodular goitre with exophthalmos and negative TRAb: an atypical diagnostic challenge

      ea0117p308
    • Double Discordance: A case of double assay interference complicating the management of Grave's Disease

      ea0117p309
• ePoster Presentations
• • Adrenal and Cardiovascular
  • • Steroid induced hypertensive crisis- a rare presentation of pheochromocytoma

      ea0117ep1
    • Steroid Weaning and Adrenal Recovery in different causes of Cushing's Syndrome

      ea0117ep2
    • The silent burn-out: opioid-induced adrenal insufficiency in a middle-aged male

      ea0117ep3
  • Bone and Calcium
  • • Not just a biochemical oddity: asymptomatic hypocalcaemia with a genetic basis

      ea0117ep4
    • Persistent Alkaline Phosphatase (ALP) Elevation as a Marker of Vertebral Paget's Disease

      ea0117ep5
  • Endocrine Cancer and Late Effects
  • • Anaplastic thyroid carcinoma masquerading as subacute thyroiditis: A diagnostic challenge with rapidly fatal outcome[rdquo]

      ea0117ep6
  • Metabolism, Obesity and Diabetes
  • • Intensive vs standard blood pressure control in type 2 diabetes: cardiovascular and microvascular outcomes

      ea0117ep7
    • Proinsulin secretion as a rare cause of hypoglycaemia in a 65-year-old man

      ea0117ep8
    • Monogenic Obesity in a Familial Cluster: Insights into Laurence-Moon-Bardet-Biedl Syndrome (LMBBS) & Lectin Deficiency associated with Genetic Variantsin BBS12 and LEPR Gene

      ea0117ep9
    • Prevalence and associated risk factors of retinopathy of prematurity in preterm infants

      ea0117ep10
    • Assessment of the antidiabetic potential of portulaca oleracea extract in a cadmium chloride-induced rat model: targeting insulin sensitivity, dyslipidemia, and oxidative stress pathways

      ea0117ep11
  • Neuroendocrinology and Pituitary
  • • When hormones tell a deeper story: neurosarcoidosis revealed by central hypogonadism and diabetes insipidus

      ea0117ep12
    • Carcinoid heart disease; current trends and controversies: a systematic review

      ea0117ep13
  • Reproductive Endocrinology
  • • Is there a role for testosterone replacement post-gonadectomy in patients with Complete Androgen Insensitivity Syndrome (CAIS)?

      ea0117ep14
    • XXY/XX mosaicism with female phenotype a rare entity

      ea0117ep15
    • Down-Klinefelter syndrome (48,XXY,+21); a case report

      ea0117ep16
  • Late Breaking
  • • When the aorta was innocent: a CT aortogram unveiling an adrenal pheochromocytoma in a hypertensive crisis

      ea0117ep17
    • Catecholamine storm: beyond endocrine origins

      ea0117ep18
    • Diagnosis of pheochromocytoma with lung metastases in a middle-aged hypertensive male following presentation of abdominal pain

      ea0117ep19
    • Severe ACTH-Independent Cushing Syndrome Due to Adrenocortical Carcinoma Unmasked Following a Fall

      ea0117ep20
    • A case of myxoedema presenting with type 2 respiratory failure

      ea0117ep21
    • Multifocal papillary thyroid carcinoma presenting on histological background of lymphocytosis

      ea0117ep22